Recall Down, Cancer Detection Up With Digital Breast Tomosynthesis
Researchers examined recall and cancer detection rates for digital breast tomosynthesis (DBT) versus digital mammography (DM).
Breast Cancer
Herceptin Hylecta Approved for the Treatment of HER2-Overexpressing Breast Cancer
The Food and Drug Administration (FDA) has approved Herceptin Hylecta (trastuzumab and hyaluronidase-oysk) for the treatment of HER2-overexpressing breast cancer. Herceptin Hylecta is a combination of trastuzumab, an HER2/neu receptor antagonist, and hyaluronidase, an endoglycosidase used to increase the dispersion and absorption of coadministered drugs when administered subcutaneously. The product contains the same active ingredient…
Pretreatment BMI Influences Weight Changes After Adjuvant Chemotherapy for Early-Onset Breast Cancer
Using a cohort of women from the POSH Study, researchers sought to determine risk factors for changes in weight among younger, premenopausal women receiving adjuvant chemotherapy for early-stage breast cancer.
Internet-Based CBT Program Improves Management of Menopausal Symptoms in Breast Cancer Survivors
A randomized study sought to determine if an Internet-based cognitive behavioral therapy program focused on managing treatment-induced menopausal symptoms has the potential to help breast cancer survivors adhere to long-term endocrine therapy.
Negative Body Image Persists for Women Undergoing Risk-Reduction Mastectomy
A prospective study sought to measure levels of satisfaction at 1 year and at long term (6 to 20 years) after prophylactic RRM in women with no cancer diagnosis (bilateral mastectomy) and in those with a breast cancer diagnosis (contralateral mastectomy).
Nurse-Led vs Oncologist-Led Breast Cancer Follow-up Program: Early Feasibility Results of an Ongoing Study
Early feasibility results are presented for a trial that evaluates whether standard-of-care follow-up for women with early-stage breast cancer can be replaced by a nurse-led intervention focusing on patient self-management.
Immunotherapy for HER2-positive Breast Cancer: Recent Advances and Combination Therapeutic Approaches
[Breast Cancer: Targets and Therapy] A review of the potential of immunotherapy along and in combination with standard therapies for breast cancer, in particularly HER2-positive expressing subtypes.
FDA: Number of U.S. Women With Breast Implant-Caused Cancer Has Increased
Textured breast implants linked to cases of anaplastic large cell lymphoma.
Performance of Work-Related Functions Linked to Cancer Treatment in Adolescent, Young Adult Survivors
Survey results reveal the effects of cancer treatment on job-related mental and physical abilities in survivors who were AYAs at diagnosis.
Overview of the Genetic Basis Toward Early Detection of Breast Cancer
[Breast Cancer: Targets and Therapy] This review examines the characteristics of cancer genome, cancer genetics, and cancer epigenetic, and focuses on discussing both genetic and nongenetic factors responsible for the predisposition of breast cancer in humans.
Next post in Publishers Alliance
